News

Chugai Pharmaceutical Co., Ltd. announced that it filed an application with the Ministry of Health, Labour and Welfare (MHLW) for approval of additional indications for the anti-SARS-CoV-2 monoclonal antibody RONAPREVE for prophylaxis of COVID-19 and treatment of asymptomatic...

The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group. Hyderabad-based Bharat Biotech had completed Phase-2 and Phase-3 trials of Covaxin on children below 18 years of...

Brii Biosciences Limited a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced the filing of an emergency use authorization (EUA) application for its investigational SARS-CoV-2 (virus that causes COVID-19)...

Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus® in Spain, for the treatment of chronic obstructive pulmonary disease (COPD). COPD...

Sweden and Denmark said they are pausing the use of Moderna's (MRNA.O) COVID-19 vaccine for younger age groups after reports of possible rare cardiovascular side effects. The Swedish health agency said it would pause using the shot for people born...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced it will build a state-of-the-art mRNA facility in Africa with the goal of producing up to 500 million doses of vaccines each year at the 50...

Metrics Contract Services, the US-based contract pharmaceutical development and manufacturing division of Mayne Pharma, announced the signing of a development and manufacturing agreement with ESSA Pharmaceuticals. Under the terms of the agreement, Metrics will provide formulation development, analytical services...